Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-02-16
1992-01-28
Doll, John
Drug, bio-affecting and body treating compositions
Lymphokine
424 89, 424 92, 424 93, A61K 3900, A61K 3939
Patent
active
050842692
ABSTRACT:
Therapeutic effectiveness of antigen doses is improved by an adjuvant comprised of a mixture of lecithin in combination with a carrier which may be selected from the group consisting of non-edible oils such as mineral oil and edible triglyceride oils such as soybean oil.
REFERENCES:
patent: 3752886 (1973-08-01), Munder et al.
patent: 4053585 (1977-10-01), Allison et al.
patent: 4117113 (1978-09-01), Allison et al.
patent: 4323563 (1982-04-01), Takami et al.
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4591499 (1986-05-01), Linn et al.
Reynolds, J. A., et al., "Infection and Immunity", Jun. 1980, pp. 937-943.
Nervig et al., "Advances in Carriers and Adjuvants for Veterinary Biologics", (1984), pp. 3-9, 11-23, 51-59, 105-113, 115-119.
Jolles and Paraf, "Chemical and Biological Basis of Adjuvants", (1973), pp. 108-110.
Burgh et al., "Comparison of Inactivated Newcastle Disease Viral Vaccines Containing Different Emulsion Adjuvants", Am. J. Vet. Res., vol. 44, No. 1, pp. 72-75, (1983).
Braugh et al., "Comparison of Inactivated Newcastle Disease Viral Vaccines Containing Different Emulsion Adjuvants", Am. J. Vet. Res., 44:72-75, Jan. 1983.
Reynolds et al., "Adjuvant Activity of a Novel Metabolizable Lipid Emulsion with Inactivated Viral Vaccines", Infect. Immun., 28:937-943, Jun. 1980.
Budens Robert D.
Doll John
LandOfFree
Adjuvant for dose treatment with antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adjuvant for dose treatment with antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvant for dose treatment with antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1859861